Active, Not Recruiting
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
NCT04092270
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +43 more
- Locations
-
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States